Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV004726249 | SCV005340069 | likely pathogenic | CACNA1A-related disorder | 2024-08-06 | no assertion criteria provided | clinical testing | The CACNA1A c.1845C>A variant is predicted to result in the amino acid substitution p.Ser615Arg. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. This variant has been reported de novo in a patient with clinical features consistent with CACNA1A-related disease (Internal Data, PreventionGenetics). An alternate nucleotide change that results in the same missense change (c.1843A>C; p.Ser615Arg) has been reported in individual(s) with CACNA1A-related disease (Lipman et al. 2022. PubMed ID: 35722745). A different missense change impacting the same amino acid (c.1844G>A; p.Ser615Asn) has been reported in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/808478/). This variant is interpreted as likely pathogenic. |